Effects of antiglaucoma drops on MMP and TIMP balance in conjunctival and subconjunctival tissue

Investigative Ophthalmology & Visual Science
Tadashi ItoMitsuru Nakazawa

Abstract

To study the effects of antiglaucoma drugs on metabolism within the extracellular matrix (ECM) of the ocular surface, including corneal, conjunctival, and subconjunctival tissue. Several antiglaucoma drugs--including beta-blockers, alpha/beta-blockers, alpha1-blocker, alpha2-agonist, and prostaglandin derivative-were topically administrated to rat eyes daily for 2 weeks or were incubated with human corneal cells or human fibroblasts for 72 hours. Thereafter, expression and enzymatic activity of the matrix metalloproteinases (MMPs), a group of enzymes proteolyzing ECM and their inhibitors, called tissue inhibitors of metalloproteinase (TIMPs), were evaluated. Quantitative RT-PCR revealed significantly upregulated and downregulated expression of MMPs and TIMPs, respectively, in rat conjunctival and subconjunctival tissue on the administration of alpha/beta-blockers, alpha1-blocker, alpha2-agonist, and prostaglandin derivative, suggesting that these drugs may enhance ECM degradation. However, in contrast, beta-blocker administration caused reverse effects--that is, upregulation and downregulation of TIMPs and MMPs, respectively. Enzymatic activity of MMPs in rat conjunctival and subconjunctival tissue analyzed by biochemical assay...Continue Reading

Citations

Oct 31, 2008·The British Journal of Ophthalmology·N TeraiL E Pillunat
Nov 28, 2012·Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft·H Thieme, K K van der Velden
Apr 29, 2011·Experimental Eye Research·Stella Arthur, Louis B Cantor
Mar 1, 2012·British Journal of Pharmacology·A Rietz, Jp Spiers
Oct 15, 2014·Acta Ophthalmologica·Minna Helin-ToiviainenHannu Uusitalo
Sep 28, 2017·Expert Opinion on Therapeutic Targets·Jeffrey O'CallaghanPete Humphries
Mar 8, 2019·Cutaneous and Ocular Toxicology·Emine SenUfuk Elgin
Oct 21, 2016·Current Opinion in Ophthalmology·Chelvin C A SngKeith Barton
Aug 5, 2019·Graefe's Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Für Klinische Und Experimentelle Ophthalmologie·Monika E DanielewskaMarek Rękas
Jan 7, 2017·Graefe's Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Für Klinische Und Experimentelle Ophthalmologie·Chong-Da ChenLin Miao
Aug 28, 2020·Clinical Ophthalmology·Larae ZimprichJustin A Schweitzer

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.